Age-not Charlson Co-morbidity Index-predicts for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung cancer
Purpose: In this single institution retrospective study of patients with stage I medically inoperable non-small cell lung cancer (NSCLC) treated with stereotactic ablative radiotherapy (SABR) we attempt to model overall survival (OS) using initial prognostic variables with specific attention on the...
Main Authors: | Oliver Edwin Holmes, Robert MacRae, Graham Cook, Peter Cross, Vimoj Nair, Horia Marginean, Jason R. Pantarotto |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-08-01
|
Series: | Clinical and Translational Radiation Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405630817300010 |
Similar Items
-
Age-adjusted charlson comorbidity index and 30-day morbidity in pelvic surgeries
by: Sampada B Dessai, et al.
Published: (2018-01-01) -
Coding algorithms for defining Charlson and Elixhauser co-morbidities in Read-coded databases
by: David Metcalfe, et al.
Published: (2019-06-01) -
Charlson comorbidity index in predicting deaths in COVID-19 patients
by: A. V. Svarovskaya, et al.
Published: (2022-04-01) -
Impact of Charlson Comorbidity Index adjusted to age in prognosis after endovascular abdominal aortic aneurysm repair
by: Vania Constâncio Oliveira, et al.
Published: (2023-03-01) -
Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden
by: Ludvigsson JF, et al.
Published: (2021-01-01)